These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17091340)

  • 1. Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis.
    Sukegawa-Hayasaka K; Kato Z; Nakamura H; Tomatsu S; Fukao T; Kuwata K; Orii T; Kondo N
    J Inherit Metab Dis; 2006 Dec; 29(6):755-61. PubMed ID: 17091340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients.
    Sukegawa K; Tomatsu S; Fukao T; Iwata H; Song XQ; Yamada Y; Fukuda S; Isogai K; Orii T
    Hum Mutat; 1995; 6(2):136-43. PubMed ID: 7581397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of four mutations on the expression of iduronate-2-sulfatase in mucopolysaccharidosis type II.
    Bonuccelli G; Di Natale P; Corsolini F; Villani G; Regis S; Filocamo M
    Biochim Biophys Acta; 2001 Nov; 1537(3):233-8. PubMed ID: 11731225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular investigations of a novel iduronate-2-sulfatase mutant in a Chinese patient.
    Lau KC; Lam CW
    Clin Chim Acta; 2008 Jun; 392(1-2):8-10. PubMed ID: 18331837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of 63 Chinese patients with mucopolysaccharidosis type II: Functional characterization of seven novel IDS variants.
    Zhang W; Xie T; Sheng H; Shao Y; Lin Y; Jiang M; Xu A; Su X; Liu Z; Zhao X; Liu L; Huang Y
    Clin Chim Acta; 2019 Apr; 491():114-120. PubMed ID: 30639582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Li P; Bellows AB; Thompson JN
    J Med Genet; 1999 Jan; 36(1):21-7. PubMed ID: 9950361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational spectrum of the iduronate-2-sulfatase (IDS) gene in 36 unrelated Russian MPS II patients.
    Karsten S; Voskoboeva E; Tishkanina S; Pettersson U; Krasnopolskaja X; Bondeson ML
    Hum Genet; 1998 Dec; 103(6):732-5. PubMed ID: 9921913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Bunge S; Steglich C; Beck M; Rosenkranz W; Schwinger E; Hopwood JJ; Gal A
    Hum Mol Genet; 1992 Aug; 1(5):335-9. PubMed ID: 1303211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.
    Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T
    Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hunter disease in a girl caused by R468Q mutation in the iduronate-2-sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele.
    Sukegawa K; Song XQ; Masuno M; Fukao T; Shimozawa N; Fukuda S; Isogai K; Nishio H; Matsuo M; Tomatsu S; Kondo N; Orii T
    Hum Mutat; 1997; 10(5):361-7. PubMed ID: 9375851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 6 new mutations in the iduronate sulfatase gene. Mutation in brief no. 233. Online.
    Vallance HD; Bernard L; Rashed M; Chiu D; Le G; Toone J; Applegarth DA; Coulter-Mackie M
    Hum Mutat; 1999; 13(4):338. PubMed ID: 10220152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations.
    Kim CH; Hwang HZ; Song SM; Paik KH; Kwon EK; Moon KB; Yoon JH; Han CK; Jin DK
    Hum Mutat; 2003 Apr; 21(4):449-50. PubMed ID: 12655569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of normal and mutant iduronate-2-sulphatase conformation.
    Parkinson-Lawrence E; Turner C; Hopwood J; Brooks D
    Biochem J; 2005 Mar; 386(Pt 2):395-400. PubMed ID: 15500445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II.
    Kato T; Kato Z; Kuratsubo I; Tanaka N; Ishigami T; Kajihara JI; Sukegawa-Hayasaka K; Orii K; Isogai K; Fukao T; Shimozawa N; Orii T; Kondo N; Suzuki Y
    J Hum Genet; 2005; 50(8):395-402. PubMed ID: 16133661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: New mutations in the iduronate-2-sulfatase (IDS) gene.
    Filocamo M; Bonuccelli G; Corsolini F; Mazzotti R; Cusano R; Gatti R
    Hum Mutat; 2001 Aug; 18(2):164-5. PubMed ID: 11462244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COS cell expression studies of P86L, P86R, P480L and P480Q Hunter's disease-causing mutations.
    Millat G; Froissart R; Cudry S; Bonnet V; Maire I; Bozon D
    Biochim Biophys Acta; 1998 Mar; 1406(2):214-8. PubMed ID: 9573369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II).
    Chang JH; Lin SP; Lin SC; Tseng KL; Li CL; Chuang CK; Lee-Chen GJ
    Hum Genet; 2005 Feb; 116(3):160-6. PubMed ID: 15614569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.